Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2766]

ESMO 2016: Reporting of adverse events in targeted therapy and immunotherapy trials is “suboptimal”

ESMO 2016: Reporting of adverse events in targeted therapy and immunotherapy trials is “suboptimal”

IMRT associated with reduction in patient reported xerostomia

IMRT associated with reduction in patient reported xerostomia

ASTRO 2016: Medulloblastoma patients should receive both chemotherapy and radiation post-surgery

ASTRO 2016: Medulloblastoma patients should receive both chemotherapy and radiation post-surgery

ASTRO 2016: Intermediate risk prostate cancer may be well controlled with brachytherapy alone

ASTRO 2016: Intermediate risk prostate cancer may be well controlled with brachytherapy alone

$ASTRO 2016: Promising toxicity results for intermediate risk prostate cancer patients undergoing extreme hypofractionation$

ASTRO 2016: Promising toxicity results for intermediate risk prostate cancer patients undergoing extreme...

ASTRO 2016: Reduced radiation boost volume recommended but craniospinal axis dose remains unchanged for average-risk paediatric medulloblastoma

ASTRO 2016: Reduced radiation boost volume recommended but craniospinal axis dose remains unchanged for average...

Fighting cancer with sticky nanoparticles

Fighting cancer with sticky nanoparticles

Precision medicine trial first of its kind to show benefit to patients

Precision medicine trial first of its kind to show benefit to patients

Many adolescent girls with leukaemia are not being screened for pregnancy before beginning chemotherapy

Many adolescent girls with leukaemia are not being screened for pregnancy before beginning chemotherapy

Study shows how Chinese medicine kills cancer cells

Study shows how Chinese medicine kills cancer cells

More from ecancer